SCHEMBL8208718

SCHEMBL8208718

C[N+](C)(C)CCCCCCC[N+](C)(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
ACHE P22303 4/20 1.00
APEX1 P27695 3/20 1.00
NFKB1 P19838 2/20 1.00
KDM4E B2RXH2 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
PMP22 Q01453 2/20 1.00
LMNA P02545 2/20 1.00
HSD17B10 Q99714 1/20 1.00
HRH3 Q9Y5N1 1/20 1.00
TSHR P16473 1/20 1.00
RAB9A P51151 1/20 1.00
NPSR1 Q6W5P4 1/20 0.92
DNM1 Q05193 6/20 0.73
APAF1 O14727 1/20 0.65
HSP90AA1 P07900 1/20 0.65
RAD52 P43351 1/20 0.65
BBOX1 O75936 1/20 0.47
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30019398 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
SCHEMBL6933263 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
SCHEMBL17898629 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
SCHEMBL17898630 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
SCHEMBL6931794 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
Decamethonium SCHEMBL238400 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
SCHEMBL12126378 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
Hexamethonium SCHEMBL34900 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
Pentamethonium SCHEMBL61798 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1
SCHEMBL12198121 1.00 MEN1 (1.00) MEN1KMT2AACHEAPEX1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4065513-A1 ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS BASF CORPORATION (US) 2022-10-05 EP claimed
WO-2022173419-A1 ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS BASF CORPORATION (US) 2022-08-18 WO claimed
US-20250382189-A1 ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS BASF MOBILE EMISSIONS CATALYSTS LLC (US) 2025-12-18 US disclosed
US-12428305-B2 Zeolite structure synthesized using mixtures of organic structure directing agents BASF MOBILE EMISSIONS CATALYSTS LLC (US) 2025-09-30 US disclosed
US-12252632-B2 Chemical-mechanical polishing composition, rinse composition, chemical- mechanical polishing method, and rinsing method ENTEGRIS, INC. (US) 2025-03-18 US disclosed
US-20230348287-A1 ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS BASF MOBILE EMISSIONS CATALYSTS LLC 2023-11-02 US disclosed
US-20230348287-A1 ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS BASF MOBILE EMISSIONS CATALYSTS LLC 2023-11-02 US disclosed
US-11720018-B2 Chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-08 US disclosed
US-20230152692-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-18 US disclosed
US-20220372329-A1 CHEMICAL-MECHANICAL POLISHING COMPOSITION, RINSE COMPOSITION, CHEMICAL-MECHANICAL POLISHING METHOD, AND RINSING METHOD ENTEGRIS, INC. 2022-11-24 US disclosed
CN-114258421-A Chemical mechanical polishing composition, cleaning composition, chemical mechanical polishing method and cleaning method CMC材料株式会社 2022-03-29 CN disclosed
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-29 US disclosed
US-9645498-B2 Developer and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-05-09 US disclosed
US-20160262384-A1 POLYCATIONIC AMPHIPHILES AS ANTIMICROBIAL AGENTS TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-09-15 US disclosed
US-20160242413-A1 POLYCATIONIC AMPHIPHILES AS ANTIMICROBIAL AGENTS TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-08-25 US disclosed
US-20160195813-A1 DEVELOPER AND PATTERNING PROCESS USING THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-07-07 US disclosed
US-20070000067-A1 Use of an effervescent product to clean soiled dishes by hand washing PROCTER & GAMBLE COMPANY, THE 2007-01-04 US disclosed
US-6060260-A MIXING POSITIVELY CHARGED MOLECULE WITH A QUATERNARY AMMONIUM BLOCKING AGENT TO PREVENT MOLECULE FROM STICKING TO NEGATIVELY CHARGED SURFACE OF ANALYZERS DADE BEHRING INC. (US) 2000-05-09 US disclosed
EP-0541442-B1 Process for the synthesis of a MTT-type zeolite, products obtained and use thereof in adsorption and catalysis ELF AQUITAINE (FR) 1997-03-26 EP disclosed
EP-0541442-A1 Process for the synthesis of a MTT-type zeolite, products obtained and use thereof in adsorption and catalysis ELF AQUITAINE (FR) 1993-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160195813-A1 DEVELOPER AND PATTERNING PROCESS USING THE SAME BMPR1A, RER1, BMPR1B MEN1 837/4885KMT2A 1730/4885ACHE 4583/4885
US-20160242413-A1 POLYCATIONIC AMPHIPHILES AS ANTIMICROBIAL AGENTS C1R, CBR3, C9 MEN1 2763/4885KMT2A 4255/4885ACHE 3703/4885
US-20160262384-A1 POLYCATIONIC AMPHIPHILES AS ANTIMICROBIAL AGENTS C1R, CBR3, C9 MEN1 3047/4885KMT2A 3961/4885ACHE 4445/4885
US-20180086948-A1 ADHESIVE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING A BIO-ELECTRODE, AND SALT SLC9A1, FN1, EPCAM MEN1 1394/4885KMT2A 1734/4885ACHE 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.